AlphaCentric Advisors’s BioXcel Therapeutics BTAI Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-40,000	Closed	-$746K	–	236
2023 Q1	$746K	Sell	40,000 -10,000	-20%	-$187K	0.52%	68
2022 Q4	$1.07M	Hold	50,000	–	–	1.06%	30
2022 Q3	$591K	Buy	+50,000	New	+$591K	0.61%	52
2021 Q4	$1.02M	Buy	50,000 +15,000	+43%	+$305K	0.3%	31
2021 Q3	$1.06M	Buy	35,000 +10,000	+40%	+$303K	0.27%	24
2021 Q2	$727K	Hold	25,000	–	–	0.2%	40
2021 Q1	$1.08M	Hold	25,000	–	–	0.36%	22
2020 Q4	$1.16M	Buy	25,000 +5,000	+25%	+$231K	0.48%	14
2020 Q3	$867K	Sell	20,000 -5,000	-20%	-$217K	0.42%	16
2020 Q2	$1.33M	Buy	+25,000	New	+$1.33M	0.75%	6